Skip to article frontmatterSkip to article content
Site not loading correctly?

This may be due to an incorrect BASE_URL configuration. See the MyST Documentation for reference.

Why terpenes matter to industry

Terpenes are one of the few chemical families that sit at the center of several distinct industries at once. This section surveys where the value is, what the evidence actually supports, and what is at stake when the data behind a terpene decision is wrong.

Market context

Market-research estimates for the standalone terpenes market vary widely with scope. Published 2025 valuations range from roughly USD 0.7 billion to USD 1.6 billion, with forecasts approaching USD 3 billion by 2035 Precedence Research, 2025Market.us, 2025; flavors and fragrances are consistently reported as the largest application segment. The adjacent essential-oils market is estimated at roughly USD 10–14 billion in 2025 IMARC Group, 2025, and aromatherapy at about USD 10 billion Grand View Research, 2025. These are third-party estimates with different methodologies and should be read as an order of magnitude rather than as a precise size. The more useful observation is structural: terpenes are a comparatively small ingredient market that gates decisions in several very large product markets (beverages, personal care, home care, cannabis, supplements, pharmaceuticals). Their information value exceeds their ingredient value.

Flavor and fragrance

Terpenes are the backbone of natural aroma chemistry. Citrus, pine, mint, floral, herbal, spicy, and woody notes are largely terpene-driven, and terpene-derived molecules (menthol, linalool, geraniol, citral, citronellol, nerol, and their esters) are among the highest-volume flavor and fragrance ingredients in the world. Myrcene is not used much directly but is the industrial intermediate for many of them.

Safety and regulatory status in this sector is comparatively mature. The Flavor and Extract Manufacturers Association (FEMA) Expert Panel has evaluated aliphatic and aromatic terpene hydrocarbons and reaffirmed their “generally recognized as safe” (GRAS) status for use as flavoring substances in food, based in part on their self-limiting organoleptic properties Adams et al., 2011. On the fragrance side, the picture is more nuanced: the autoxidation products of limonene and linalool are among the most frequently detected contact allergens in dermatology clinics, with one consecutive patch-test series reporting positive reactions to limonene hydroperoxides in 9.4% and to linalool hydroperoxides in 11.7% of patients tested Dittmar & Schuttelaar, 2019. European cosmetic regulation has responded with labeling requirements and ongoing scientific-committee review. For a formulator, that means the oxidation state of a terpene ingredient is a compliance variable, not just a quality variable.

The data requirement here is identity and stereochemistry at the level a perfumer works at, together with regulatory status (FEMA number, GRAS determination, EU flavouring or allergen listing, IFRA standard) attached to the right isomer.

Cannabis and hemp

Terpenes are how cannabis products differentiate. Cannabinoid content is largely commoditized; the aroma and the perceived character of a cultivar are terpene-driven, and consumers, budtenders, and brands increasingly talk in terpene language. Regulators have followed. California limits the terpenes that may be added to inhalable cannabis products to those naturally occurring in cannabis that contribute to its natural flavor and aroma California Department of Cannabis Control, 2023, and Oregon’s review of non-cannabis additives stresses that natural occurrence or food-GRAS status does not establish safety for inhalation Oregon Liquor and Cannabis Commission, 2020. Terpene profiles on certificates of analysis are now a routine part of product release in most regulated markets.

The scientific story is more careful than the marketing story, and the gap matters commercially. The influential 2011 review by Russo proposed that terpenes could modulate the effects of cannabinoids, the so-called entourage effect Russo, 2011. Fifteen years later, the evidence is mixed. Preclinical work has shown that several cannabis terpenes are cannabimimetic in mice and can enhance cannabinoid activity in a receptor-dependent way LaVigne et al., 2021. β-Caryophyllene is a genuine, selective CB2 receptor agonist (Ki ≈ 155 nM) and is a common dietary constituent, which makes it the best-characterized “dietary cannabinoid” in the class Gertsch et al., 2008. In humans, a 2024 double-blind, placebo-controlled crossover trial in twenty healthy adults found that vaporized d-limonene dose-dependently reduced the anxiety and paranoia induced by inhaled THC without altering THC’s other subjective effects Spindle et al., 2024. That is a real, specific, clinically measured interaction. It is not evidence that every terpene enhances every cannabinoid. A comprehensive 2024 review concluded that synergistic or additive enhancement of cannabinoid efficacy by terpenes “remains unproven” and called for clinical trials André et al., 2024.

For a brand, the implication is that “myrcene is sedating” and “limonene is uplifting” are hypotheses with some preclinical support, not substantiated claims, and that the regulatory and reputational risk of stating them as facts is rising. For a lab or a producer, the implication is that the terpene profile itself, measured well and reported honestly, is the defensible asset.

Essential oils and aromatherapy

Essential oils are, chemically, terpene mixtures with a minority of phenylpropanoids and other volatiles. The sector is large, consumer-facing, and lightly regulated, which makes it both an opportunity and a liability. There is credible mechanistic work: linalool vapor produces anxiolytic behavior in mice that is abolished in anosmic animals and blocked by the benzodiazepine antagonist flumazenil, indicating an olfactory route to GABAA-mediated effects Harada et al., 2018. There is also a long history of claims that outrun evidence, and enforcement actions against disease claims on essential-oil products in several jurisdictions.

The data requirement is composition: what is actually in this oil, at what percentage, from which botanical and geographic source, and how variable is that across batches. Terpedia ingests EssoilDB and related composition data precisely so that “lavender oil” can be resolved into a distribution of linalool, linalyl acetate, camphor, and 1,8-cineole rather than a name.

Functional foods and beverages

The fastest-growing terpene application is arguably the one with the least settled vocabulary: foods and beverages that carry terpenes for both flavor and an implied function. Hemp-derived terpene blends in chews, seltzers, and gummies; citrus terpenes positioned for mood; hop terpenes in non-alcoholic beer. The regulatory line between a flavor and a structure/function claim is sharp in the United States and the European Union, and the substantiation standard for the latter is high.

Terpedia’s partnership with MONDAYS (described in Partnership example: MONDAYS) is a worked example of doing this responsibly: each product page publishes the measured terpene profile of the product, every compound at or above 0.05% of total volatiles with the milligrams it contributes to a 20 mg terpene dose, and links each molecule to the underlying science on a separate reference site where laboratory-dose findings are labeled as such. Composition is stated; effects are not.

Pharmaceuticals

Terpenoids are among the most successful natural-product scaffolds in medicine. Artemisinin, a sesquiterpene lactone from Artemisia annua, and its derivatives are the backbone of modern antimalarial therapy. Paclitaxel, a diterpenoid originally isolated from Taxus brevifolia, is a first-line anticancer agent. Both illustrate the drug-discovery value of the class and its formulation challenges: poor water solubility, restricted bioavailability, and the need for semisynthetic optimization.

β-Caryophyllene’s selective CB2 agonism Gertsch et al., 2008 has made it a candidate for inflammatory and neuropathic pain and is the subject of ongoing preclinical and early clinical work. More broadly, the terpene chemical space is enormous, largely uncharacterized biologically, and increasingly accessible to computational target prediction. That is the space Terpedia’s research program on protein docking and terpene–protein interaction ranking is designed to organize (see Research portfolio).

Industrial biotechnology

Engineered microbes now produce terpenes at commercial scale. Amyris demonstrated yeast-based production of the sesquiterpene farnesene from sugar feedstocks; valencene, historically distilled from citrus oil in low yield and at the mercy of seasonal supply, is produced in engineered Saccharomyces cerevisiae and converted to the high-value grapefruit aroma nootkatone Song et al., 2024. Global valencene production has been estimated at roughly 10,000 kg per year, about half of it consumed in nootkatone manufacture Song et al., 2024. As biosynthetic routes proliferate, the questions a buyer must answer change: is this molecule “natural” under the relevant flavor regulation, what is its isomer purity, and what trace by-products does the production host contribute? Those are, again, identity and provenance questions.

Agriculture and pest management

Many terpenes are insect repellents, attractants, or antifeedants in their native ecological roles, and several are registered biopesticide active ingredients. Nootkatone is registered in the United States as an insect repellent. Limonene, pine oil, and thyme oil appear in minimum-risk pesticide formulations. This sector is small relative to the others but is growing as synthetic-pesticide restrictions tighten, and it draws on the same occurrence, composition, and safety data.

What is at stake

Across all of these sectors, the cost of bad terpene data falls into four buckets:

  1. Formulation errors when a supplier’s name, a lab’s name, and a regulatory list’s name refer to different isomers or different compounds.

  2. Quality failures when batch-to-batch or lab-to-lab variability is misread as product variability or, worse, hidden.

  3. Compliance exposure when marketing copy states effects that the literature treats as hypotheses, or when an additive that is food-GRAS is assumed to be inhalation-safe.

  4. Wasted expert time reconciling sources by hand: the same reconciliation done again in every company, every quarter.

The next section explains why the public data landscape makes these failures so easy, and the section after it explains what Terpedia does about it.

References
  1. Precedence Research. (2025). Terpene market size to hit USD 2.95 billion by 2035. https://www.precedenceresearch.com/terpene-market
  2. Market.us. (2025). Terpenes market size, share, growth. https://market.us/report/terpenes-market/
  3. IMARC Group. (2025). Essential oils market size and industry report 2034. https://www.imarcgroup.com/essential-oils-market
  4. Grand View Research. (2025). Aromatherapy market size and share report, 2026–2033. https://www.grandviewresearch.com/industry-analysis/aromatherapy-market
  5. Adams, T. B., Gavin, C. L., McGowen, M. M., Waddell, W. J., Cohen, S. M., Feron, V. J., Marnett, L. J., Munro, I. C., Portoghese, P. S., Rietjens, I. M. C. M., & Smith, R. L. (2011). The FEMA GRAS assessment of aliphatic and aromatic terpene hydrocarbons used as flavor ingredients. Food and Chemical Toxicology, 49(10), 2471–2494. 10.1016/j.fct.2011.06.011
  6. Dittmar, D., & Schuttelaar, M. L. A. (2019). Contact sensitization to hydroperoxides of limonene and linalool: results of consecutive patch testing and clinical relevance. Contact Dermatitis, 80(2), 101–109. 10.1111/cod.13137
  7. California Department of Cannabis Control. (2023). Guidance: requirements for inhaled cannabis products. https://cannabis.ca.gov/2023/11/guidance-requirements-for-inhaled-cannabis-products
  8. Oregon Liquor and Cannabis Commission. (2020). Non-cannabis additives in inhalable cannabinoid products. https://www.oregon.gov/olcc/Docs/commission_agendas/2020/Non-Cannabis-Addtives-in-Inhalable-Cannabinoid-Products.pdf
  9. Russo, E. B. (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology, 163(7), 1344–1364. 10.1111/j.1476-5381.2011.01238.x
  10. LaVigne, J. E., Hecksel, R., Keresztes, A., & Streicher, J. M. (2021). Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity. Scientific Reports, 11, 8232. 10.1038/s41598-021-87740-8
  11. Gertsch, J., Leonti, M., Raduner, S., Racz, I., Chen, J.-Z., Xie, X.-Q., Altmann, K.-H., Karsak, M., & Zimmer, A. (2008). Beta-caryophyllene is a dietary cannabinoid. Proceedings of the National Academy of Sciences, 105(26), 9099–9104. 10.1073/pnas.0803601105
  12. Spindle, T. R., Zamarripa, C. A., Russo, E., Pollak, L., Bigelow, G., Ward, A. M., Tompson, B., Sempio, C., Shokati, T., Klawitter, J., Christians, U., & Vandrey, R. (2024). Vaporized D-limonene selectively mitigates the acute anxiogenic effects of delta-9-tetrahydrocannabinol in healthy adults who intermittently use cannabis. Drug and Alcohol Dependence, 257, 111267. 10.1016/j.drugalcdep.2024.111267
  13. André, R., Gomes, A. P., Pereira-Leite, C., Marques-da Costa, A., Monteiro Rodrigues, L., Sassano, M., Rijo, P., & Costa, M. do C. (2024). The entourage effect in cannabis medicinal products: a comprehensive review. Pharmaceuticals, 17(11), 1543. 10.3390/ph17111543
  14. Harada, H., Kashiwadani, H., Kanmura, Y., & Kuwaki, T. (2018). Linalool odor-induced anxiolytic effects in mice. Frontiers in Behavioral Neuroscience, 12, 241. 10.3389/fnbeh.2018.00241
  15. Song, Y., Liu, H., Quax, W. J., Zhang, Z., Chen, Y., Yang, P., Cui, Y., Shi, Q., & Xie, X. (2024). Application of valencene and prospects for its production in engineered microorganisms. Frontiers in Microbiology, 15, 1444099. 10.3389/fmicb.2024.1444099